MARKSANS / NSE / Biotechnology & Drugs

Marksans Pharma

INR 233.19-19.18 (-2.59%) 1D

Last updated: 2026-06-16T06:15:00.460089+00:00

Price Chart

1Y Price Trend

Open258.05

High266.6

Low155

Close249.76

Volume16,33,878

Change-8.29

Change %-3.21%

Key Information

Ticker SymbolMARKSANS

Current Price233.19

52-Week High270.7

52-Week Low155

Market Cap10,578.52

Beta1.51

Volume16,33,878

ISININE750C01026

Day High256

Day Low248.75

Open255

Recommendations

RatingStrong Buy

Target High270.6

Target Low156

Target Mean1.5

Target Median62.5

Risk Metrics

Overall RiskBalanced risk

Board Risk41.98

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app

News

Latest stock news

Add Marksans Pharma Ltd for the Target Rs. 290 by Choice Institutional Equities - Investment Guru6 days ago

Market news

Add Marksans Pharma Ltd for the Target Rs. 290 by Choice Institutional Equities Investment Guru

Marksans Pharma to attend Choice Institutional Equities conference - scanx.trade8 days ago

Market news

Marksans Pharma to attend Choice Institutional Equities conference scanx.trade

Marksans Pharma to Acquire Netherlands-Based QliniQ BV - Machine Maker11 days ago

Market news

Marksans Pharma to Acquire Netherlands-Based QliniQ BV Machine Maker

Marksans FY26 PAT rises 9.8% to ₹420.1 crore - scanx.trade13 days ago

Market news

Marksans FY26 PAT rises 9.8% to ₹420.1 crore scanx.trade

Marksans Pharma launches Saksham Niveshak campaign for KYC updates - scanx.trade15 days ago

Market news

Marksans Pharma launches Saksham Niveshak campaign for KYC updates scanx.trade

Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals - Markets Mojo15 days ago

Market news

Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals Markets Mojo

Marksans Pharma Acquires Dutch Firm QliniQ BV, Expands EU Footprint - Medical Dialogues15 days ago

Market news

Marksans Pharma Acquires Dutch Firm QliniQ BV, Expands EU Footprint Medical Dialogues

Marksans Pharma expands in Europe with acquisition of QliniQ - BusinessLine16 days ago

Market news

Marksans Pharma expands in Europe with acquisition of QliniQ BusinessLine